日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Anti-Müllerian hormone: a novel biomarker for aggressive prostate cancer? Emerging evidence from a prospective study of radical prostatectomies

抗苗勒氏管激素：侵袭性前列腺癌的新型生物标志物？来自根治性前列腺切除术前瞻性研究的新证据

期刊:Hormones-International Journal of Endocrinology and Metabolism
影响因子:2.5
doi:10.1007/s42000-023-00520-z
Kontogiannis, Stavros; Markantes, Georgios; Stamou, Maria; Tsagkarakis, Michail; Mamali, Irini; Giannitsas, Konstantinos; Perimenis, Petros; Georgopoulos, Neoklis; Athanasopoulos, Anastasios
肿瘤
前列腺癌
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis

IAP 拮抗剂 Birinapant 和 AT-406 可与 TRAIL、BRAF 或 BCL-2 抑制剂有效协同作用，使 BRAFV600E 结直肠肿瘤细胞对凋亡敏感

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-016-2606-5
Philippos Perimenis, Apostolos Galaris, Alexandra Voulgari, Margarita Prassa, Alexander Pintzas
信号转导
肿瘤
肿瘤细胞
Apoptosis
发表日期：2016
文献求助 收藏

Deep sedation in GreenLight laser prostatectomy

GreenLight激光前列腺切除术中的深度镇静

期刊:Urology Annals
影响因子:0.8
doi:10.4103/0974-7796.177195
Fligou, Fotini; Kallidonis, Panagiotis; Flaris, Nicolaos; Al-Aown, Abdulrahman; Kyriazis, Iason; Vasilas, Marinos; Panagopoulos, Vasilis; Perimenis, Petros; Liatsikos, Evangelos; Vrettos, Theofanis
发表日期：2016
文献求助 收藏

Parameters predicting postoperative unilateral disease in patients with unilateral prostate cancer in diagnostic biopsy: a rationale for selecting hemiablative focal therapy candidates

预测单侧前列腺癌患者术后单侧疾病的参数（诊断性活检）：选择半消融局部治疗候选者的理论依据

期刊:Cuaj-Canadian Urological Association Journal
影响因子:2
doi:10.5489/cuaj.268
Sfoungaristos, Stavros; Perimenis, Petros
肿瘤
前列腺癌
肿瘤免疫
发表日期：2013
文献求助 收藏

Clinical and pathological variables that predict changes in tumour grade after radical prostatectomy in patients with prostate cancer

前列腺癌根治性前列腺切除术后肿瘤分级变化的临床和病理变量

期刊:Cuaj-Canadian Urological Association Journal
影响因子:2
doi:10.5489/cuaj.270
Sfoungaristos, Stavros; Perimenis, Petros
肿瘤
前列腺癌
肿瘤免疫
发表日期：2013
文献求助 收藏

PSA density is superior than PSA and Gleason score for adverse pathologic features prediction in patients with clinically localized prostate cancer

在临床局限性前列腺癌患者中，PSA密度比PSA和Gleason评分更能预测不良病理特征。

期刊:Canadian Urological Association Journal
影响因子:
doi:10.5489/cuaj.11079
Sfoungaristos, Stavros; Perimenis, Petros
肿瘤
前列腺癌
肿瘤免疫
PSA
发表日期：2012
文献求助 收藏